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Abstract
The development of different neurological disorders has been associated with the
accumulation of reactive oxygen species (ROS). Elevated ROS levels can disrupt the
neuronal electrical activity. This phenomenon has been seen during epilepsy and
neurodegenerative diseases like Parkinson’s disease. Furthermore, the excess of ROS and
development of such disorders have been linked to neuronal cell death partly due to
excessive, non-physiological glutamate release. Ferroptosis is a recently defined irondependent cell death mechanism. Inducible by a small molecule called erastin, ferroptosis
was first described in cancer cells. Erastin-induced ferroptosis differs from apoptosis,
necrosis and autophagy, since it leads to different biochemical and morphological
changes, compared to the other cell death mechanisms. It is characterized by the
accumulation of iron-dependent lethal ROS. Interestingly, both ferroptosis and glutamate
excitotoxicity are associated with an increase in ROS levels. Moreover, both erastininduced ferroptosis in cancer cells and glutamate-induced cell death in neurons can be
inhibited by Ferrostatin-1 (Fer-1), a small molecule bearing antioxidant properties. This
suggest that both cell death mechanisms share a similar lethal pathway that can be
rescued by Fer-1. To better understand the neuroprotective properties of Fer-1, the
morphological and electrophysiological changes induced by glutamate excitotoxicity and
erastin were examined and compared to conditions where Fer-1 is present. The proposed
project employed cell cultures, immunostaining and in vitro electrophysiological
experiments in hippocampal slices from mice.
vii
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Chapter I. Introduction
I.1 Ferroptosis – an iron-dependent non-apoptotic cell death mechanism
Death is a word that often times alarms people, however at a cellular level, death
is a mechanism that is needed in order to maintain homeostasis within many tissues and
systems (Fuchs and Steller, 2011). Apoptosis is a physiological programmed cell death
mechanism that has been extensively described. The regulation of apoptosis is critical to
avoid

the

development

of

different

developmental,

neurodegenerative

and

hyperproliferative diseases such as cancers (Fuchs and Steller, 2011; Dixon et al., 2012;).
This programmed cell death mechanism involves the activation of proteins like caspases,
and physiological cell changes like nucleus condensation (which is a hallmark of this
mechanism) without obvious cell membrane disruption. (Yuan and Kroemer, 2010; Fuchs
and Steller, 2011). However, studies have shown that there are other types of cell death
pathways that can be involved during the development of different pathological
conditions (see Dixon et. al., 2012).
The development of many neurodegenerative disorders is associated with an impairment
of neuronal activity, sometimes leading to cell death. As previously mentioned, cell death
can be induced by different mechanisms. Previous studies have shown that induction of
cell death by different small molecules like erastin and RSL3 involve iron (Cheah et al.,
2006; Dixon et al., 2012; Skouta et al., 2014; Do Van et al., 2016). Based on recent in-vitro
studies, a new form of iron-dependent non-apoptotic cell death called ferroptosis has
been defined (Dixon et al., 2012; Skouta et al., 2014; Do Van et al., 2016; Cao and Dixon,
1

2016). Evidence show that ferroptosis differs from apoptosis since it shows no activation
of caspases, release of mitochondrial cytochrome c and morphological changes like
chromatin fragmentation (Dixon et al., 2012; Do Van et al., 2016; Cao and Dixon, 2016). In
comparison to other cell death mechanisms like apoptosis, necrosis, and autophagy,
ferroptosis seems to lead to morphological changes such as smaller mitochondria with a
greater membrane thickness (Table 1) (Dolma et al., 2003; Cao and Dixon, 2016).
Moreover, ferroptosis has been shown to increase the accumulation of intracellular
reactive oxygen species (ROS) that affect cell function as well as to decrease the levels of
glutathione (GSH), an important antioxidant (Mattson, 2000; Dixon et al., 2012; Cao and
Dixon, 2016).
Table 1. Biochemical and morphological characteristic changes of different cell death
mechanisms. (Modified from Cao and Dixon, 2016).

Type of cell death

Biochemical changes

Morphological changes

Apoptosis

Caspases activation,
fragmentation.

DNA

Rounded cell shape, decreased
volume of cell, damaged nucleus
(size and fragmentation) and
chromatin condensation.

Necrosis

Reduced ATP levels and
activation and hyperactivation
of signaling pathways.

Disrupted plasma membrane,
swelling of cytoplasm and
organelles, and some chromatin
condensation.

Autophagy

Substrate degradation.

Increase in doubled-membrane
autophagic vacuoles and no
chromatin condensation.

Ferroptosis

Reactive oxygen species (ROS)
imbalance, iron accumulation,
reduction of glutathione.

Rounded cell shape, smaller
mitochondria and condensed
membrane, regular nucleus and
no chromatin condensation.
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I.2 Erastin and excitotoxic glutamate levels as inducers of cell death
Ferroptosis was discovered while cell death induced by Ras-selective lethal (RSL)
compounds was being studied (Yagoda et al., 2007; Dixon et al., 2012). In about 30% of
different cancers, there is a mutation in the RAS GTPase superfamily (Dixon et al., 2012).
The mutant Ras is a small GTPase protein that, under non-pathological conditions, is
important for many signaling pathways like cell growth, migration and the programmed
cell death mechanism – apoptosis (Fernández-Medarde and Santos, 2011; Cao and Dixon,
2016). However, mutations in RAS genes can lead to the production of permanently
overactivated Ras proteins. Such RAS mutants are oncogenes and have been associated
with the development of molecular abnormalities and cancer (Fernández-Medarde and
Santos, 2011; Dixon et al., 2012). Previous studies have provided evidence that small
molecules like erastin can induce cell death using RAS mutant cell lines. However, results
indicate that the erastin-induced death does not show typical apoptotic features such as
chromatin fragmentation (Cao and Dixon, 2016). In fact, erastin-induced death involves
a unique set of morphological, biochemical, and genetic features suggesting that erastin
act as an inducer of ferroptosis. Furthermore, the erastin-dependent cell death was shown
to be inhibited by iron chelators and lipophilic antioxidants, which indicate that erastininduced cell death depends on the iron-dependent accumulation of ROS (Weinreb et al.,
2013; Cao and Dixon, 2016). Interestingly, the accumulation of ROS has a high impact on
lipid membranes. Therefore, it has been suggested that ferroptosis, the erastin-induced
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cell death pathway, includes ROS formation leading to the lipid peroxidation of cell
membranes (Dixon et al, 2012; Do Van et al., 2016).
Another process that has been described to be iron-dependent is excitotoxic cell death in
the nervous system. This oxidative, iron-dependent cell death is usually seen in strokes
and epilepsy as well as in neurodegenerative diseases like Parkinson’s disease
characterized by the deterioration of the substantia nigra pars compacta (SNpc) (Choi,
1988; Linert et al., 2000; Dixon et al., 2012; Do Van et al., 2016). One of the most studied
inducers of excitotoxicity is glutamate. At physiological levels, glutamate is very
important for neuron-neuron communication at synapses, as well as for physiological
processes like axonal and neuronal growth and guidance (Lai et al., 2014). Glutamate is
the major excitatory neurotransmitter in the central nervous system (CNS). Usually,
under resting conditions, the extracellular levels of glutamate are kept low (nanomolar)
by glutamate transporters and increase only during synaptic transmission (≈ 500-1000
µM) (Choi, 1988) when it is actively released. However, under pathological conditions, it
has been demonstrated that high levels of glutamate (beyond physiological values; > 3
mM for example) can cause neuronal damage and loss, as seen in different neurological
diseases (Choi, 1988; Dixon et al., 2012). Furthermore, high levels of glutamate are linked
to the inhibition of the biosynthesis of intracellular glutathione, leading to the
accumulation of lipid reactive oxygen species, similar to what is seen during ferroptosis
(Dixon et al., 2012; Cao and Dixon, 2016). Given the neurotoxic nature of an excess of
glutamate and the fact that it can lead to an oxidative iron-dependent cell death process,
4

it has been suggested that glutamate-induced lethal effects could be related to erastininduced ferroptosis. Previous studies conducted by Dixon et. al. in 2012, demonstrated
that the exposure of rat organotypic hippocampal slice cultures (OHSCs) to excitotoxic
glutamate levels can induce cell death similar to the effects of erastin on oncogenic RASmutated cell culture (Dixon et al., 2012). Because the glutamate-induced cell death was
rescued by iron chelation in OHSCs, it was concluded that glutamate-induced death in
OHSCs and erastin-induced death in cancer cells share a common lethal mechanism of
action that can be inhibited by iron chelation. Therefore, it is tempting to speculate that
an excess of glutamate can kill neurons by a ferroptotic-like mechanism.
I.3 Inhibition of Ferroptosis by Ferrostatin-1
Ferroptosis can be induced by various molecules like erastin and, as suggested
above, maybe also by cytotoxic levels of glutamate. Interestingly, both erastin-induced
Ferroptosis and glutamate-induced cell death can be inhibited by another small molecule
named Ferrostatin-1 (Fer-1) (Dixon et al., 2012; Skouta et al., 2014). Fer-1 is a small
molecule with a radical scavenger activity that was recently synthesized and used to test
its possible therapeutic effects on disease models such as stroke, Huntington’s Disease
and Epilepsy (Dixon et al., 2012; Skouta et al., 2014; Skouta, 2016; Do Van et al., 2016).
Previous studies have provided evidence that Fer-1 can inhibit the effects of RSL-induced
cell death. Furthermore, Fer-1 did not inhibit cell death induced by apoptotic agents or
cell death induced by other oxidative lethal compounds. This suggests that Fer-1
specifically counteracts RSL-induced cell death, as was shown using erastin-induced cell
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death in cancer cells (Dixon et al., 2012). Although the exact pathway by which iron
contributes to ferroptosis and how Fer-1 can interfere in this process needs to be
described in more details, it is clear that Fer-1 can inhibit the damage to membrane lipids
and therefore it can prevent cell death induced by ferroptosis (Skouta et al., 2014; Do Van
et al., 2016). Besides the findings of the role of ferroptosis in cancer, it has been suggested
that ferroptosis inhibition can have a neuroprotective effect and can therefore prevent the
development of different neurological disorders (Dixon et al., 2012; Skouta et al., 2014).
Previous results hence strongly suggest that Fer-1 can have a protective effect on cells
and on hippocampal tissue exposed to cytotoxic levels of glutamate, equivalent to
pathological conditions such as epilepsy.
I.4 SH-SY5Y cells as a neuronal model
There are different cell lines that are widely used as models to study neurological
diseases (Zhang et al., 2014). While conclusions obtained from data using cell cultures
might not be directly translatable to neuronal tissue (Zhang et al., 2014; Do Van et al.,
2016), many cell cultures like the human neuroblastoma SH-SY5Y cell line and the Lund
human mesencephalic (LUHMES) are well established neuronal cell models which are
widely used. The SH-SY5Y cells have the ability to produce Dopamine (DA) and
noradrenaline (NA). Although when undifferentiated, this cell line cannot be considered
as purely dopaminergic, SH-SY5Y cells have been extensively used as neuronal models
to study dopamine-dependent neurodegenerative diseases (Xicoy et al., 2017).
Remarkably, this cell line can be differentiated to have a neuronal-phenotype (Forster et
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al., 2016). Previous protocols used Retinoic Acid (RA) to differentiate SH-SY5Y cells into
neuron-like cells. Indeed, once differentiated, these cells showed prolonged extensions or
neurites (Forster et al., 2016).
Moreover, recent studies used LUHMES cells to study neurological diseases and the
effect of Erastin and other cell death inducers on the viability of these cells (Do van et al.,
2016). Work done by Do Van et al., 2016, demonstrated that certain cells can be killed by
erastin-induced ferroptosis. In that study, Do Van and collaborators tested three different
culture cell lines, including SH-SY5Y cells. After incubation with Erastin (0 – 6M), the
viability of the three cell lines was tested by staining with the supravital dye propidium
iodide (0.5M), and the number of surviving cells was evaluated/quantified using flow
cytometry. Their results showed that Erastin-induced ferroptosis killed LUHMES cells
exclusively, since the SH-SY5Y cells and the motor neuron-like NSC-34 cells remained
largely unaffected by the Erastin treatment (Figure 1.1). Interestingly, their data also
showed that all cell lines could be killed via an apoptotic mechanism, although the
LUHMES cells were affected to a lesser extent than the other cell lines (Do Van et al.,
2016). These results suggest that LUHMES and SH-SY5Y cells can be further used to
understand in more details the mechanism of action used by of Erastin to induce
ferroptosis.
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Figure 1.1. The effect of various cell death inducers on LUHMES, NSC-34 and SHSY5Y cells.
The graphs show the cell viability as a function of treatment concentration on Luhmes, NSC-34
and SH-SY5Y cells. The treatments were as follows: Erastin to induce ferroptosis, Rapamycin to
induce Autophagy and Staurosporine to induce Apoptosis. As seen on the first graph, Erastin
only decreased the viability of Luhmes cells via ferroptosis, without affecting SH-SY5Y and
NSC-34 cells, (Do Van et al., 2016).

Glutamate excitotoxicity has been linked to neuronal cell death similar to what has been
observed during epilepsy (Murphy et al., 1989; Sundstrom et al., 2005; Dixon et al., 2012).
In addition to these findings, studies performed by Dixon et al., 2012, suggest that OHSCs
incubated with excitotoxic glutamate levels can be linked to ferroptosis-like effect.
Therefore, OHSCs were co-incubated with glutamate (5mM) and Fer-1 (2M) and other
iron chelators to determine if glutamate-induced neurotoxicity could be rescued by a
ferroptosis inhibitor. Results were analyzed on three different regions of the organotypic
hippocampal slices, the dentate gyrus (DG), CA1 and CA3 fields. Results showed that
glutamate excitotoxicity induced cell death in all the three regions analyzed.
Interestingly, the co-incubation of an excess of glutamate with Fer-1 diminished the
glutamate-induced cell death in all three hippocampal regions (Dixon et al., 2012) (Figure
1.2).
8

Figure 1.2. Glutamate effects on Organotypic hippocampal slice cultures (OHSCs). Images
showing OHSCs exposed to 5 mM glutamate and glutamate + 2 µM Fer-1. OHSC were stained
with propidium iodide (PI) to indicate cell death (Dixon et al., 2012).

I.5 ROS accumulation and its correlation to neurological disorders
Many neurological diseases involve an abnormal accumulation of ROS (Dixon et
al., 2012; Brožíčková and Otáhal, 2013). Iron-dependent lipid radical species
accumulation has been implicated in Parkinson’s Disease, strokes and epilepsy (Choi,
1988; Morrison et al., 2002; Brožíčková and Otáhal, 2013; Do Van et al., 2016). At
physiological concentrations, radical species like Nitric Oxide (NO) contribute to
neuronal activity. NO is a physiological regulator of synaptic transmission and plasticity
(Garthwaite et al., 1998; Brožíčková and Otáhal, 2013), however at higher concentrations,
NO can also harm neuronal network activity due to its reactivity. In fact, NO imbalances
have been involved in different neurodegenerative diseases and in epilepsy (Giux et al.,
2005; Brožíčková and Otáhal, 2013). During epilepsy-related seizures, the levels of NO
are increased and the electrical activity of neurons in brain regions like the hippocampus
9

is affected (Brožíčková and Otáhal, 2013). Epileptic-like activity can be elicited in vitro in
rodent hippocampal slices using an excess of glutamate (Do Van et al., 2016). Therefore,
since: 1- glutamate excitotoxicity can lead to NO imbalances and abnormal electrical
activity in hippocampal neurons; and 2- the effects of glutamate excitotoxicity can be
rescued by the ROS-dependent ferroptotic antagonist Fer-1, it was suggested that the
cellular mechanisms underlying neuronal epileptiform activity might be linked to
ferroptosis induction (Cater et a., 2007; Dixon et al.,2012).

I.6 Specific Aims
Therefore here, we used cells in culture and mouse hippocampal slices to further
understand the effects of erastin and glutamate and the neuroprotective properties of
Ferrostatin-1. We tested our hypothesis that glutamate excitotoxicity share ferroptotic
properties by disrupting neuronal cell structure and function in a similar way. To test our
hypothesis, we designed the following specific aims:
Specific Aim 1: Determine whether glutamate-dependent excitotoxicity and erastininduced ferroptosis lead to similar morphological changes. The "control" SH-SY5Y
neuronal-like cell line was cultured and differentiated and treated with erastin. In
addition, mouse hippocampal slices were incubated with either glutamate or erastin, in
the absence and presence of Fer-1. Subsequently, immunocytochemistry was used to
analyze the morphological changes of culture cells and hippocampal neurons induced by
the different treatments.
10

Specific Aim 2: Determine whether Fer-1 can rescue the abnormal in vitro
electrophysiological

activity

of

hippocampal

neurons

induced

by

glutamate

excitotoxicity. We performed extracellular field electrophysiological recordings on acute
hippocampal brain slices from WT mice. During these in vitro recordings, high levels of
glutamate were first added to the perfusing solution to elicit epileptiform activity in CA3
hippocampal neurons. Then, the ferroptotic antagonist Fer-1 was bath applied to
determine whether this small antioxidant molecule can restore the abnormal electrical
activity of hippocampal neurons towards normal values.
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Chapter II. Experimental Approach
II.1 Specific Aim 1: Determine whether glutamate-dependent excitotoxicity and
ferroptosis lead to similar morphological changes in cell culture and hippocampal
neurons.
II.1.1 Objective and Overview
As mentioned above, erastin can induce ferroptosis in different cell cultures. Indeed,
LUHMES cells incubated with erastin showed a decreased viability, whereas SH-SY5Y
cell line were unaffected by erastin (Figure 1.1) (Do Van et al., 2016). The rationale for
using the SH-SY-5Y cells line relies here was to use them as a control and confirm that we
could replicate published data. Interestingly, the morphological changes consequent to
erastin were not investigated in differentiated SH-SY5Y cells. Moreover, comparing effect
of Fer-1 on cytotoxic glutamate or erastin exposure using mouse hippocampal neurons
in vitro remained to be done. Therefore, the main goal of this aim was to identify the
morphological changes induced by erastin or an excess of glutamate and to determine
whether such morphological changes could be prevented (or reversed) by Fer-1. To
address this aim, I first used the SH-SY5Y cell line. These cells were differentiated and
incubated with erastin. I used these cells as "control" since we expected to see no erastininduced changes on their morphology, according to previous reports. I then performed
immunocytochemical experiments to label and quantify morphological features such as,
neurite and nucleus morphology under the different experimental conditions (i.e., drug
treatments). Second, I used mouse hippocampal slices either under control conditions or
12

incubated either with glutamate or erastin, In the absence and presence of Fer-1. Then I
used confocal microscopy and Immunohistochemistry to examine the soma of these
hippocampal neurons under the different experimental conditions
II.1.2 Materials and Methods
Cell culture: SH-SY5Y (donated by Dr. Rachid Skouta’s laboratory, Chemistry
department, The University of Texas at El Paso, USA) cells were grown on T75 flasks
(Corning, USA) in Dulbecco’s modified Eagle’s Medium (DMEM) (Corning, USA),
supplemented with 10% fetal bovine serum and 1 % streptomycin in in 5% CO2/95% air
at 37°C. During cell culture, complete medium was changed every three to four days and
cells passaged before 90% confluency.
Cell differentiation: For cell differentiation, about 8X105 cells were seeded onto glass
coverslips (Fisher, USA, Cat # 12-545-100) in a six-wells plate (VWR, USA, cat. #10062892) in complete medium. After twenty-four hours, cells were treated with differentiation
medium containing 10% fetal bovine serum, 1 % streptomycin and 0.1% Retinoic acid
(RA) (Sigma, USA, cat. #R2625). Medium containing RA was changed every two days for
five consecutive days in order to induce a neuronal phenotype. A negative and a positive
control were always included on each experiment. Our negative control consisted of
undifferentiated cells; the positive control was the differentiated cells treated with
Retinoic Acid.
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Treatments: 10µM erastin was applied to the cells either before the end of the cell
differentiation (i.e., co-incubation) OR after the cell differentiation period (i.e., postincubation)
a)

During the co-incubation condition, cells were treated with differentiation

medium along with erastin. The incubation was interrupted on day 6 to perform
immunocytochemistry. This protocol was identified as "co-incubation treatment". Here,
medium was renewed every two days.
b)

In a subset of experiments, erastin was added to the cells after complete

differentiation was obtained. Some cells were co-treated with Fer-1. Cells were incubated
for 24 hours with the treatment and then incubation was stopped to proceed with fixation
and immunohistochemical staining; this protocol was identified as "post-incubation
treatment". Differentiation media was changed every 2 days.
Immunocytochemistry of SH-SY5Y cells: Once attached to glass coverslips, the cells
treated under the different conditions mentioned above, were fixed with 4%
paraformaldehyde (PFA) for 20 minutes at 4°C, followed by incubation with
permeabilization buffer (Phosphate Buffered Saline (PBS), Bovine serum albumin (BSA)
and detergent) for 10 minutes at room temperature. Cells were then blocked with
blocking solution (10% normal goat serum (NGS) (abcam, USA, cat. #ab138478), 1% BSA
and 0.15% saponin in PBS) for 1 hour at 4°C. Subsequently, primary antibodies were
added and incubated overnight at 4°C followed by incubation with secondary antibodies
for 1 hour at room temperature in the dark. The coverslips were then washed and
14

mounted on glass slides with Pro-Long Gold antifade reagent with DAPI (Invitrogen,
USA, cat. #P36931).
Confocal microscopy: LSM 700 Confocal Zeiss microscope system was used to obtain and
analyze the images of the stained SH-SY5Y cells. For the length measurements of
neuronal processes, the processes were traced and measured using the 2009 ZEN
software (Zeiss). A cell was considered as neurite-bearing if it contained at least one
neuronal process that was longer than the soma of the cell.
Slice preparation: Mice aged between 1 – 3 months were anesthetized with 1.5%
isoflurane (Vedco, Saint Joseph, Missouri) followed by decapitation. Brains were
cautiously extracted and transferred to cold oxygenated artificial cerebrospinal fluid
(aCSF). Acute horizontal hippocampal slices were cut using a vibratome (Leica
Instruments). Slices were cut at a 150µm thickness and at speed of 0.07m/s. Slices were
then transferred to a beaker containing oxygenated aCSF at a temperature of ~28°C. Slices
were then allowed to recover during a 2-hour incubation period in oxygenated aCSF.
Glutamate, erastin and Fer-1 incubation of hippocampal slices: Following the 2-hr
recovery period, hippocampal slices were transferred to beakers containing the following
drugs dissolved in aCSF: glutamate (7mM), erastin (10M), glutamate (7mM) + Fer-1
(100 M) and erastin (10M) + Fer-1 (100 M), all final concentrations. A subset of slice
were incubated in aCSF only, as a control condition. The incubation time for each
experimental condition was about an hour, this to mimic the conditions of the field
electrophysiological recordings experiments (see Aim 2 below, for more details).
15

Immunohistochemistry: Following the 1-hr incubation, all hippocampal slices were fixed
with 4% PFA for three days at 4°C. Then, the 4% PFA or cryoprotectant solution was
rinsed with Tris-buffered saline (TBS; pH 7.4), 5 times (5 minutes each time), at room
temperature. Slices were then incubated with blocking solution 10X TBS, (NDS) (normal
donkey serum; EMD-Millipore, Billerica, MA; catalog #S30-100ML; lot NG1827420) and
Triton X-100; Sigma-Aldrich, St. Louis, MO; catalog #T8532 in TBS) for 1 hour at room
temperature. Slices were incubated with nissil green neurotrace for ~1 hour in the dark
at room temperature. Slices were then mounted on superfrost slides containing 50%
glycerol and 50% 10X TBS and covered with a coverslip.
Confocal microscopy: LSM 700 Confocal Zeiss microscope system was used to visualize
the slides and acquire/analyze the images. The area of interest was the CA3 regions of
the hippocampus, where the epileptic-like activity was recorded during the extracellular
field electrophysiological experiments. The soma of neurons of subfields within the CA3
region was measured and quantified using statistical analysis.
II.2 Specific Aim 2: Determine whether Fer-1 can rescue the abnormal in vitro
electrophysiological

activity

of

hippocampal

neurons

induced

by

glutamate

excitotoxicity
II.2.1 Objective and Overview
Glutamate excitotoxicity has been extensively studied and linked to neuronal injury or
cell death (Dixon et al., 2012; Do Van et al., 2016; Kandeda et al., 2017). Subsequent to
excessive glutamate receptor activation, calcium influx rises, which is in part responsible
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for cell injury (Emerit et al., 2004; Kandeda et al., 2017). Glutamate excitotoxicity can be
associated to epileptogenesis (Kandeda et al., 2017) and the overproduction of reactive
oxygen species (Azam et al., 2010). Because of this, glutamate excitotoxicity has been
previously used to induce epilepsy or cell death in in vitro models (Dixon et al., 2012; Do
Van et al., 2016; Kandeda et al., 2017). The overproduction of reactive oxygen species has
been established as a hallmark of ferroptosis (Dixon et al., 2012; Skouta et al., 2014; Kabiraj
et al., 2015; Skouta, 2016; Cao and Dixon 2016). Therefore, it has been suggested that there
is a link between ferroptosis, glutamate excitotoxicity and epilepsy (Dixon et al., 2012; Do
Van et al., 2016). Studies performed by Dixon et al., 2012 showed that glutamate can
induce cell death in organotypic hippocampal culture slices, more specifically in the DG,
CA1 and CA3 regions. Furthermore, it has been shown that Fer-1 can alleviate the effects
of high glutamate levels in OHSC (Dixon et al., 2012). However, the effects of Fer-1 on
the electrical activity of hippocampal brain slices exposed to high levels of glutamate had
not been yet established. Therefore, the goal of this aim was to further understand
whether the aberrant electrical activity induced by cytotoxic glutamate levels could be
rescued by Fer-1 in hippocampal neurons. To do so, we used extracellular field
electrophysiological recordings in acute hippocampal slices from WT mice. Glutamateinduced epileptiform activity was evaluated in the absence and the presence of 100 µM
Fer-1. Results from this aim should help understanding the mechanisms underlying the
neuroprotective effects of Fer-1. Ideally, our results could also contribute to the
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development of new therapies for disorders involving ferroptosis-dependent
mechanisms.
II.2.2 Materials and Methods
Animals: C57BL/6 female and male mice aged between 2-3 months were obtained from
Jacksons Laboratories. The animals were accommodated at The University of Texas at El
Paso (UTEP). Mice were kept in the UTEP Bioscience Research Bldg Vivarium under
conditions according to UTEP Institutional Animal Care and Use Committee (IACUC)
protocols and maintained on a 12-hour light and dark cycle.
Hippocampal slice preparation: Mice were anesthetized with 1.5% isoflurane (Vedco,
Saint Joseph, Missouri) followed by decapitation. Brains were extracted and transferred
to

cold

oxygenated

cerebrospinal
horizontal

fluid

artificial

(ACSF).

hippocampal

slices

Acute
were

obtained using a vibratome (Leica
Instruments). Slices were cut at a 300µm
thickness and at a speed of 0.07m/s. Slices
were

then

re-sized

to

isolate

the

hippocampus section, and then transferred

Figure 2.1. Viability test in the CA1
region of the hippocampus. Cell
viability is measured by placing a
stimulating electrode onto CA3
neuronal fibers and a recording
electrode in the CA1 region (stratum
radiatum) of the hippocampus.

to a perfusing chamber that continuously perfused hippocampal slices with oxygenated
aCSF. Slices were allowed to recover during a 2-hour incubation period during which
they were maintained at a temperature of approx. 30°C. After the recovery period, slices
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were tested for viability by placing a concentric bipolar platinum radium electrode on the
CA1 region of the hippocampus and then applying an electric shock to the CA1 afferent
fibers. The recordings were performed by placing a pulled glass micropipette electrode
on the CA3 region.
Extracellular field recordings: Following a two-hour recovery period and during the
recordings, hippocampal slices were continuously perfused with oxygenated aCSF. An
initial electrical test stimulation was performed by placing a concentric bipolar platinum
radium electrode on the CA3 fibers and recording with a pulled glass micropipette
electrode place within the CA1 region (Figure 2.1). This test confirmed the viability of the
brain tissue prior to the induction of the epileptiform activity. Then, 7mM glutamate was
added to the perfusing solution to induce epilepsy-like events. Subsequently, once the
glutamate-induced epileptic-like events were consistent and stable, 100 µM Fer-1 was
added to the glutamate-containing perfusing solution, in an attempt to neuro-protect the
slice from cytotoxicity. All the recordings were acquired and saved using the pClamp 10
software and the analysis of the events was performed
using the Clampfit program.
Glutamate and Fer-1 treatments: Glutamic acid (7mMfinal concentration) was dissolved
in aCSF to induce epileptic-like events as previously published (Dixon et al., 2012;
Kandeda et al., 2017). The induction of the epileptic-like events was recorded for 5
minutes in the pyramidal cell layer of the hippocampus CA3 region (Figure 2.2). After
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this first recording, 100 µM Fer-1 was be added to the slice perfusing solution for 20
minutes followed by a
recording period of 10 minutes. Finally,
Fer-1 will was washed out to revert back
to the “pre” Fer-1 conditions, and
therefore, confirm any Fer-1 effect. All
perfusing

solutions

were

kept

fully

oxygenated during the entire extent of the
experiments.
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Figure 2.2. In vitroElectrophysiological
recordings. The glutamate-induced
epileptic-like events were recorded using
a pulled glass microelectrode on the CA3
region of the hippocampus in the absence
and in the presence of Fer-1.

Chapter III. Results
The understanding of the excitotoxic effects of both glutamate and erastin and
the neuroprotective properties of Fer-1 on hippocampal neurons requires both
morphological and electrophysiological analysis. In order to understand the
morphological changes induced by erastin and glutamate, immunostaining was used on
cell culture and hippocampal tissue from mice. Furthermore, to examine the electrical
activity of hippocampal neurons under the exposure of these compounds, in vitro
extracellular field recordings were performed in mouse hippocampal slices. The results
from these experiments are described below.
III.1. Effect of erastin on SH-SY5Y cells
To understand the morphological effects induced by erastin on cell culture,
immunocytochemistry was performed on the SH-SY5Y cell line. Cells were induced to a
neuronal phenotype by exposure to Retinoic Acid (RA), this to better understand the
effects of erastin on mature cells. A negative control consisting of undifferentiated SHSY5Y cells was included as well (Figure 3.1) The treatments were divided into two
different conditions: co-incubation and post-incubation conditions. Cells were then
exposed to erastin and processed for immunocytochemistry. Anti-beta-3-tubulin
antibody was used to visualize the major structures of the cells as well as DAPI to
visualize the nuclei of the same cells.
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DAPI

Beta-3-tubulin

Overlay

Figure 3.1. Untreated SH-SY5Y cells. Cells not exposed to the RA treatment were cultured,
fixed and labeled with DAPI (blue) and beta-3-tubulin. These cells were included as negative
control.

III.1.1. Post-incubation with erastin
About 8X105 cells were seeded onto glass coverslips in a six-wells plate for each
experiment. SH-SY5Y cells were first incubated with RA in order to induce a mature
phenotype (Figure 3.2). After six days of incubation with RA, 10M erastin was added to
the cells and incubated for 24 hours. Cells were then processed for immunocytochemistry
and slides were viewed under a confocal microscope. Measurements of the cell structure
were taken. About ten regions from each slide were analyzed. As expected from previous
results (from Do Van et al., 2016) where no effect on cell viability was shown after
exposure to erastin, SH-SY5Y cells were not significantly affected morphologically. The
general shape of the cells remained the same for the positive control i.e., the untreated
differentiated cells, similar to the differentiated cells exposed to erastin (Figure 3.3).
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DAPI

Beta-3-tubulin

Overlay

Figure 3.2. SH-SY5Y cells incubated with RA. SH-SY5Y were differentiated using RA and
showed a neuronal phenotype. Cells were then fixed and labeled with beta-3-tubulin (green)
and DAPI (blue).

DAPI

Beta-3-tubulin

Overlay

Figure 3.3. SH-SY5Y cells post-incubated with erastin. Cells were first induced to a neuronal
phenotype by incubating with RA, followed by 24 hr treatment with erastin. Cells are labeled
with DAPI in blue for the nucleus and beta-3-tubulin in green.

III.1.2. Co-incubation with erastin
To understand the effect of erastin on differentiated SH-SY5Y cells, these cells
were co-incubated with erastin. About 8X105 cells were seeded onto glass coverslips in a
six-wells plate for each experiment. Cells were incubated with both RA and 10M erastin
23

for six days. Media was renewed every two days. After the incubation period, cells were
fixed and processed for immunocytochemistry. After visualizing the cells under the
microscope, I found that, similarly to post-incubated treated cells, there was no change
in the overall morphology on the cells as seen on (Figure 3.4).

DAPI

Beta-3-tubulin

Overlay

Figure 3.4. SH-SY5Y cells post-incubated with erastin. Cells were co-incubated with RA and
erastin for 6 days. Cells were then fixed and stained with DAPI (blue) and anti-beta-3-tubulin.

III.1.3. Soma analysis of hippocampal neurons exposed to glutamate, erastin and Fer-1
In order to mimic the field electrophysiological experiments that were performed
with glutamate and Fer-1, mouse hippocampal slices were incubated using similar
experimental conditions (Figure 3.5). The purpose of these experiments was to analyze
whether morphological changes were associated with the perfusion of these drugs.
During the electrophysiological field experiments (described in the next section, below),
brain tissue was exposed to glutamate for about 1 hour and then to glutamate + Fer-1 for
around 1 hour as well. Similar conditions were used here: hippocampal slices, that would
be visualized for neuronal morphological changes, were exposed to glutamate, or erastin
24

in the absence and presence of Fer-1. This was done to compare the effects on cells' soma
size by the different conditions. A total of 3 brains were obtained, cut and incubated with
the corresponding treatments. After the incubation time, slices were fixed and processed
for immunohistochemistry (Figure 3.5). Slices were observed under a confocal
microscope. The CA3 region of the hippocampus was identified with a magnification of
5X and 20X, and then cells from the same region were focused and measured with a
magnification of 40X. Different areas from the CA3 region were captured and soma of
neurons were measured using the tools from the Zeiss ZEN software. 50 neurons were
measured from each slice, having a total of 150 soma measurements from each condition.
My results show glutamate exposure increased the soma size of hippocampal neurons,
and Fer-1 was able to reduce this increase in soma size, back to normal, control values
(Figure 3.5; ANOVA, p<0.05). Erastin and Erasting+Fer-1 solutions had no effects on Fer1, similar to the SH-SY5Y cell results.
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Figure 3.5. Hippocampal slices. Slices were stained and visualized under a confocal microscope
at different magnifications (from left to right: 5X, 20X and 40X). Graph showing the
quantification of the soma size measurements under the different experimental conditions.

III.2. Electrophysiological characterization of hippocampal neurons induced to
excitotoxicity
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To investigate whether Fer-1 can rescue the abnormal in vitro activity of
hippocampal neurons induced by glutamate excitotoxicity, extracellular field
electrophysiological recordings were performed. Mice brains were obtained and 300M
acute horizontal slices containing the hippocampus were cut (Figure 3.6) (n=8). An initial
electrical stimulation was applied by placing a concentric bipolar platinum radium
electrode and recorded with a pulled glass micropipette electrode to record on the CA1
region of the hippocampus (Figure 3.7). To induce epileptiform activity, the brain tissue
was perfused with 7mM glutamate dissolved in oxygenated aCSF. The time to induce
epileptic-like events ranged from 20 minutes to 1 hour. Once epileptiform activity was
induced, recordings were made on the CA3 region of the hippocampus, followed by the
perfusion of glutamate + Fer-1 for another 30 minutes. To confirm the effect of Fer-1, a
glutamate washout was performed. The recorded epileptiform activity was analyzed
using two parameters: the frequency of the events and the amplitude of individual
events.

Figure 3.6. Illustration of mouse hippocampal slice acquisition.

26

A

B

C

Figure 3.7. Extracellular field experiments in the hippocampus. (A) Initial electrical response
after stimulation on the CA1 region. (B) Glutamate-induced epileptic-like events were recorded
in the absence (C) and in the presence of Fer-1. The Effect of Fer-1 (100µM) in the presence of
glutamate (7mM) were quantified by measuring the frequency and the amplitude of each
epileptic-like event under the different experimental conditions in the CA3 region.

To assess the field electrophysiological recordings, we analyzed the amplitude and the
frequency of the events of the last best minute on each condition. By combining all
animals (N = 8), we observed a significant decrease in the frequency of epileptic-like
events in the presence of Fer-1 (Figure 3.8; ANOVA; p<0.05). Interestingly, the amplitude
of the events remained unaffected.
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Figure 3.8. The effect of Fer-1 on the amplitude and frequency of glutamate-induced
epileptic-like events in the hippocampus. Graphs showing the effect of Fer-1 on the amplitude
(left) and frequency (right) of glutamate-induced epileptiform activity on the CA3 region of the
hippocampus. N = 8 animals. Means ± SEM.

We also analyzed the frequency and amplitude of induced epileptiform activity by
separating males and females. We used a total of four females and four males during the
field recording experiments. Interestingly, the amplitude of the events was greater in
females compared to males, however, for both genders, the amplitude of the events
remained unaffected by Fer-1. In contrast, we observed a significant decrease in the
frequency of the events in the presence of Fer-1. First, in females, the perfusion of Fer-1
significantly decreased the frequency of the events (Figure 3.9; ANOVA, p<0.05).
Similarly in males, the effect of Fer-1 seemed to have taken longer to occur, as the
significant decrease in the amplitude of the events occurred during the "washout" period,
as the Glutamate+Fer-1 solution was being replaced by a "Glutamate only" solution
(Figure

3.9)
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Figure 3.9. The effect of Fer-1 on the electrical activity of hippocampal neurons on males and
females. Graphs showing the effects of Fer-1 on the mean amplitude and frequency of the
glutamate-induced epileptiform activity in the hippocampus of male and female mice.
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Chapter IV. Discussion
The goal of our research was to first examine the morphological effect of erastin
and glutamate on cell culture and mouse hippocampal slices as well as the potential
rescue by Fer-1. Second, we wanted to understand the effect of Fer-1 on the electrical
activity in the hippocampus induced by a toxic level of glutamate to mimic the
excitotoxicity associated with several disease states. Immunostaining experiments and
electrophysiological field experiments were performed to accomplish these aims. First,
the SH-SY5Y cell line was used to assess whether erastin had an effect on the overall
shape of cells. Immunocytochemistry and confocal microscopy were used for analysis.
Previous studies have shown that erastin has no effect on the cell viability of these cells,
however there are no studies showing the effect of erastin on cell shape (Do Van et al.,
2016). Our data show that similar to the effect on cell viability, erastin does not affect cell
morphology. Next, to investigate the effect of these molecules, mouse brain slices were
used for immunohistochemistry. The soma of neurons at the CA3 region of the
hippocampus were measured under the different experimental conditions. Finally,
extracellular field electrophysiological experiments were used to assess the
neuroprotective effect of Fer-1 on hippocampal epileptiform activity induced by
glutamate. My data from these experiments show that in the presence of Fer-1, the
frequency of events was significantly decreased, compared to the "glutamate-only"
condition.

30

IV.1. Immunostaining experiments
IV.1.1 Observing effect of erastin on SH-SY5Y cells
Erastin, a ferroptosis inducer, was used on SH-SY5Y cells. It has been shown that
erastin has no effect on the cell viability of this cell line (Do Van et al., 2016). Based on this
background we expected no change on the morphology of these cells after exposure to
erastin. We analyzed the effects on both post-and-co incubation experiments. Since we
wanted to understand the effect on mature cells we sought to quantify the extensions of
the neuronal-induced cells. I found no significant changes in the extensions of these cells
under both conditions.

IV.1.2. Quantifying effect of erastin, glutamate and Fer-1 on hippocampal neurons
Horizontal mice brain slices were Incubated with glutamate or erastin, in the
absence or presence of Fer-1. The incubation time with each treatment sought to mimic
the conditions by which slices were exposed during extracellular field experiments. A
total of 750 soma size from the five groups described above. Similar to the results
obtained on the SH-SY5Y cells, there was no change in the soma size of neurons incubated
with erastin. The glutamate-exposed hippocampal neurons were found to have an
increase in the soma size compared to the control. Interestingly, the soma size of neurons
exposed to glutamate + Fer-1 showed to be similar to the size of the control group.
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IV.2 Extracellular electrophysiological field experiments
In vitro extracellular electrophysiological field recordings were performed on
acute horizontal hippocampal slices. Recordings of glutamate-induced epileptic-like
events were taken, in the presence or absence of Fer-1. The two parameters used were the
frequency and amplitude of events. These experiments can help determine the
neuroprotective effects of Fer-1 on glutamate excitotoxicity.

IV.3. Future studies
Extracellular field recording helped us to speculate that Fer-1 might be able to
restore the electrical activity induced by glutamate. The number of experiments needs be
increased to establish a neuroprotective effect. Ideally, our work would form the basis
for further functional investigation using in vivo models.

IV.4. Conclusions
Glutamate excitotoxicity and ferroptosis are two phenomenon that have been
shown to induce cell death in neurons. Furthermore, glutamate excitotoxicity is known
to be associated to abnormal electrical activity as in seen in epilepsy. Fer-1 has been
reported to ameliorate the effects induced by both erastin-induced ferroptosis and
glutamate excitotoxity. However, the effect of Fer-1 on the morphology and electrical
activity of hippocampal neurons is not well known.

32

Our objective was to investigate the neuroprotective effects of Fer-1 on both the
morphology and electrophysiological properties of hippocampal neurons induced to
glutamate excitotoxicity. To test our hypothesis, we used immunochemical staining of
hippocampal neurons. Soma size of neurons exposed to glutamate showed to have an
increase in comparison to the control neurons. Glutamate + Fer-1 exposed neurons
seemed to have a size similar to the control group. Our preliminary data from in vitro
extracellular field electrophysiological recordings showed that Fer-1 has an effect on the
frequency of epileptic-like events. This data, might suggest that Fer-1 has neuroprotective
effects that can help to restore the abnormal electrical activity induced by glutamate.
Future work could help to better establish the neuroprotective properties of Fer-1.
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